rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
2010-11-2
|
pubmed:abstractText |
The PML-RAR? oncogene is the central effector of acute promyelocytic leukemia (APL). PML-RAR? physically interacts with epigenetic-modifying enzymes including DNA methyltransferases (Dnmt) to suppress critical downstream targets. Here, we show that increased expression of Dnmt3a1 cooperates with PML-RAR? in vivo to promote early lethality secondary to myeloid expansion and dysfunction in primary mice. Bone marrow cells from these mice cause leukemogenesis with a shortened latency and a higher penetrance on transplantation into irradiated recipients. Furthermore, leukemic cells overexpressing PML-RAR? and Dnmt3a1 display increased methylation at a target promoter compared with PML-RAR? or Dnmt3a1 controls. Our findings show a cooperation between the PML-RAR? oncogene and the Dnmt3a1 enzyme in vivo and that Dnmt levels can be rate limiting in APL progression.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/K08 NS048118-01A1,
http://linkedlifedata.com/resource/pubmed/grant/K08 NS048118-02,
http://linkedlifedata.com/resource/pubmed/grant/K08 NS048118-03,
http://linkedlifedata.com/resource/pubmed/grant/K08 NS048118-04,
http://linkedlifedata.com/resource/pubmed/grant/K08 NS048118-05,
http://linkedlifedata.com/resource/pubmed/grant/K08 NS048118-06,
http://linkedlifedata.com/resource/pubmed/grant/K08 NS48118,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA095274,
http://linkedlifedata.com/resource/pubmed/grant/R01 NS057221-01A1,
http://linkedlifedata.com/resource/pubmed/grant/R01 NS057221-02,
http://linkedlifedata.com/resource/pubmed/grant/R01 NS057221-03
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1538-7445
|
pubmed:author |
|
pubmed:copyrightInfo |
©2010 AACR.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8792-801
|
pubmed:dateRevised |
2011-11-1
|
pubmed:meshHeading |
pubmed-meshheading:20861188-Animals,
pubmed-meshheading:20861188-Bone Marrow Cells,
pubmed-meshheading:20861188-DNA (Cytosine-5-)-Methyltransferase,
pubmed-meshheading:20861188-DNA Methylation,
pubmed-meshheading:20861188-Flow Cytometry,
pubmed-meshheading:20861188-Genes, Lethal,
pubmed-meshheading:20861188-Humans,
pubmed-meshheading:20861188-Inflammation,
pubmed-meshheading:20861188-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:20861188-Mice,
pubmed-meshheading:20861188-Mice, Transgenic,
pubmed-meshheading:20861188-Oncogene Proteins, Fusion,
pubmed-meshheading:20861188-Promoter Regions, Genetic,
pubmed-meshheading:20861188-Respiratory Burst,
pubmed-meshheading:20861188-Survival Rate
|
pubmed:year |
2010
|
pubmed:articleTitle |
PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.
|
pubmed:affiliation |
Institute for Regeneration Medicine, University of California, San Francisco, California 94143, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|